The pursuit of pharmacological interventions for obesity and metabolic syndrome has long focused on Human Growth Hormone (hGH). While hGH is highly effective at burning fat, its clinical use for weight loss is severely limited by adverse side effects, including insulin resistance, edema, and the promotion of unwanted cellular growth. In response to these limitations, […]
